MESNA Drug Patent Profile
✉ Email this page to a colleague
When do Mesna patents expire, and when can generic versions of Mesna launch?
Mesna is a drug marketed by Fresenius Kabi Usa, Gland, Hikma, Mylan Institutional, Rising, Sagent Pharms Inc, and Teva Pharms Usa. and is included in seven NDAs.
The generic ingredient in MESNA is mesna. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the mesna profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mesna
A generic version of MESNA was approved as mesna by FRESENIUS KABI USA on April 26th, 2001.
Summary for MESNA
| US Patents: | 0 |
| Applicants: | 7 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 120 |
| Patent Applications: | 1,498 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for MESNA |
| What excipients (inactive ingredients) are in MESNA? | MESNA excipients list |
| DailyMed Link: | MESNA at DailyMed |
Pharmacology for MESNA
| Drug Class | Cytoprotective Agent |
Medical Subject Heading (MeSH) Categories for MESNA
Anatomical Therapeutic Chemical (ATC) Classes for MESNA
US Patents and Regulatory Information for MESNA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | MESNA | mesna | INJECTABLE;INTRAVENOUS | 075811-001 | Apr 26, 2001 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Teva Pharms Usa | MESNA | mesna | INJECTABLE;INTRAVENOUS | 075764-001 | Apr 27, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan Institutional | MESNA | mesna | INJECTABLE;INTRAVENOUS | 076488-001 | Mar 8, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Gland | MESNA | mesna | INJECTABLE;INTRAVENOUS | 206992-001 | Dec 18, 2017 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hikma | MESNA | mesna | INJECTABLE;INTRAVENOUS | 075739-001 | Jan 9, 2004 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Sagent Pharms Inc | MESNA | mesna | INJECTABLE;INTRAVENOUS | 090913-001 | Apr 13, 2010 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
